Quetiapine Dosing
Quetiapine dosing varies significantly by indication, with 400-800 mg/day for acute mania and schizophrenia in adults, 300-600 mg/day for bipolar depression, and lower doses (300-600 mg/day) for pediatric patients. 1, 2
Adult Dosing by Indication
Schizophrenia (Adults)
- Initial titration: Start 25 mg twice daily on Day 1
- Increase by 25-50 mg increments on Days 2-3
- Target 300-400 mg/day by Day 4
- Therapeutic range: 150-750 mg/day (divided 2-3 times daily)
- Maximum: 750 mg/day 1, 2
Acute Mania (Adults)
- Rapid titration: Day 1: 100 mg total (divided twice daily), Day 2: 200 mg, Day 3: 300 mg, Day 4: 400 mg
- Further increases up to 800 mg/day by Day 6 in 200 mg increments
- Therapeutic range: 400-800 mg/day
- Maximum: 800 mg/day 1, 2
Bipolar Depression (Adults)
- Once-daily dosing at bedtime: Day 1: 50 mg, Day 2: 100 mg, Day 3: 200 mg, Day 4: 300 mg
- Target dose: 300 mg/day (this is also the maximum for this indication)
- This is notably lower than mania dosing 1, 2
Pediatric Dosing
Adolescent Schizophrenia (13-17 years)
- Day 1: 25 mg twice daily, Day 2: 100 mg total, Day 3: 200 mg, Day 4: 300 mg, Day 5: 400 mg
- Therapeutic range: 400-800 mg/day
- Maximum: 800 mg/day
- May divide into three times daily dosing 1, 2
Pediatric Bipolar Mania (10-17 years)
- Same titration as adolescent schizophrenia
- Therapeutic range: 400-600 mg/day (lower than adults)
- Maximum: 600 mg/day 1, 2
Special Populations
Elderly Patients
- Start: 50 mg/day
- Titration: Increase by 50 mg/day increments
- Use slower titration due to 30-50% reduced clearance
- Target lower therapeutic doses 1, 2
Hepatic Impairment
- Start: 25 mg/day
- Titration: Increase by 25-50 mg/day increments
- Quetiapine is extensively hepatically metabolized, requiring dose reduction 2
Critical Drug Interactions
CYP3A4 Inhibitors (ketoconazole, ritonavir, nefazodone)
- Reduce quetiapine dose to 1/6 of original dose
- When inhibitor discontinued, increase back 6-fold 2
CYP3A4 Inducers (phenytoin, carbamazepine, rifampin)
- Increase quetiapine up to 5-fold with chronic use (>7-14 days)
- Titrate based on response
- When inducer discontinued, reduce to original dose within 7-14 days 2
Fluvoxamine or Paroxetine
- These significantly reduce quetiapine clearance (by approximately 50-75%)
- Reduce initial dose to 8 mg/kg/day when coadministered
- With both fluvoxamine AND paroxetine: reduce to 4 mg/kg/day 3, 4
Duloxetine
- Reduces quetiapine clearance
- Reduce to 8 mg/kg/day with coadministration 4
Practical Considerations
Faster titration is possible in acute settings: Studies demonstrate that reaching 400 mg/day by Day 2-3 (rather than Day 5) is safe and well-tolerated in hospitalized patients with acute psychosis 5, 6. Some clinicians use: 300 mg Day 1,600 mg Day 2,900 mg Day 3 in severe cases 6.
The "high-dose theory" lacks robust support: Despite anecdotal reports of requiring >800 mg/day, controlled trials show 150-450 mg/day is as effective as 600-750 mg/day for schizophrenia 7. Neuroimaging suggests low dopamine receptor occupancy at standard doses, but this reflects quetiapine's low receptor affinity rather than inadequate dosing 7.
Third-line option for acute agitation: Oral quetiapine is considered third-line (after IM lorazepam, IM haloperidol combinations, and IM olanzapine) for severe agitation in mania 1.
Alzheimer's-related psychosis dosing differs: Start 12.5 mg twice daily, maximum 200 mg twice daily, with caution regarding orthostasis 8. However, recent data shows increased mortality, dementia, and falls with low-dose quetiapine versus trazodone in older adults 9.
Reinitiation: If off >1 week, restart with initial titration schedule. If off <1 week, may resume maintenance dose 2.